Sort
23,748 grants matching “melanoma”
CUTANEOUS ONCOLOGY
$108,141University Of Texas Md Anderson Can Ctr · K24 · FY2003 · CA
The PD-1/B7-H1 Pathway and Melanoma Immunity
$108,120Lieping Chen · Yale University · P50 · FY2017 · CA
FN FAK SIGNALING AXIS AND TUMORIGENESIS
$108,089University Of California San Francisco · K01 · FY2000 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$108,000Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Effects of residual PAH exposure from firefighters' turnout gear on plasma microRNA expression
$108,000Jooyeon Hwang · University Of Oklahoma Hlth Sciences Ctr · K01 · FY2021 · OH
Effects of residual PAH exposure from firefighters' turnout gear on plasma microRNA expression
$108,000Jooyeon Hwang · University Of Oklahoma Hlth Sciences Ctr · K01 · FY2022 · OH
Effects of residual PAH exposure from firefighters' turnout gear on plasma microRNA expression
$108,000Jooyeon Hwang · University Of Oklahoma Hlth Sciences Ctr · K01 · FY2020 · OH
Generation of an UV-dependent Mouse Model of Melanoma
$108,000Lidia Kos · Florida International University · SC2 · FY2009 · CA
Combination cytokine gene therapy for melanoma treatment
$107,987Ichor Medical Systems, Inc. · R43 · FY2002 · CA
Sun Exposure and Melanoma in Agricultural Workers
$107,950Leslie K Dennis · University Of Iowa · K07 · FY2009 · CA
Ultraviolet Light Induced Phenomena in Biomembranes
$107,917Irene E Kochevar · Massachusetts General Hospital · R01 · FY2006 · GM
THE ROLE OF EGFR IN UV-INDUCED SKIN CARCINOGENESIS
$107,840Creighton University · K22 · FY2002 · ES
THE ROLE OF EGFR IN UV-INDUCED SKIN CARCINOGENESIS
$107,840Creighton University · K22 · FY2003 · ES
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma
$107,838Eric Kirk Lau · Sanford Burnham Prebys Medical Discovery Institute · K99 · FY2013 · CA
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma
$107,838Eric Kirk Lau · Sanford Burnham Prebys Medical Discovery Institute · K99 · FY2014 · CA
DCTD Biopharmaceutical Development - Type 1 Diabetes RAID projects
$107,834David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
ROLES OF NITRIC OXIDE AND OXYGEN IN OCULAR MELANOMA
$107,800Duke University · R29 · FY2000 · EY
Administrative Core
$107,769James R. Heath · California Institute Of Technology · U54 · FY2014 · CA
Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
$107,687Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · K99 · FY2009 · CA
CORE--MICROSCOPIC IMAGING
$107,658W Matthew Petroll · Ut Southwestern Medical Center · R24 · FY2007 · EY
Clinical Research Office
$107,519Rafat Abonour · Indiana University Indianapolis · P30 · FY2011 · CA
ASSESSMENT OF THE MOLECULAR TARGET OF FUSAROCHROMANONE AND ITS ANALOGUES
$107,469Tara Williams-Hart · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2011 · RR
Integrating NK and DC into Cancer Therapy
$107,376Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Core B: Pathology Core
$107,316Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
ROLES OF NITRIC OXIDE AND OXYGEN IN OCULAR MELANOMA
$107,280Wayne State University · R29 · FY2001 · EY